| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $15.4M | -11.6% | -24.5% |
| SG&A Expense | $5.6M | -17.0% | -12.4% |
| Operating Income | -$20.9M | +13.1% | +21.6% |
| Pre-tax Income | -$20.3M | +12.9% | +20.9% |
| Income Tax | $0 | — | — |
| Net Income | -$20.3M | +12.9% | +20.9% |
| EPS (Basic) | -$0.12 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.3M | -10.1% | +584.1% |
| Short-term Investments | $57.1M | +535.0% | -19.8% |
| Current Assets | $61.2M | -19.3% | -28.2% |
| Total Assets | $105.0M | -14.1% | -25.3% |
| Current Liabilities | $13.2M | +4.4% | -18.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$54.3M | — | — |
| Capital Expenditures | $551K | — | — |
| Investing Cash Flow | $56.1M | — | — |
| Financing Cash Flow | $50.2M | — | — |
| Free Cash Flow | -$54.9M | — | — |
| +60.0% |
| EPS (Diluted) | -$0.12 | +14.3% | +60.0% |
| $22.1M |
| -0.9% |
| -21.0% |
| Stockholders' Equity | $82.9M | -17.0% | -26.4% |